Increased salt sensitivity secondary to leptin resistance in SHHF rats is mediated by endothelin.
A link between leptin resistance, obesity, and salt sensitivity has been suggested. SHHF/Mcc-fa(cp) rats (SHHF) were used to study the effect of gene dosage of a null mutation of the leptin receptor (cp) on salt sensitivity and response to a combined endothelin A and B receptor antagonist (bosentan). Obese (cp/cp), heterozygous (+/cp), and homozygous lean (+/+) male SHHF were fed a low salt diet (0.3% NaCl) for 7 days, followed by a high salt diet (8.0% NaCl) for 7 days. There were no significant differences in systolic blood pressure between genotypes on low salt. In response to high salt, cp/cp had significantly greater systolic pressure than +/cp and +/+. On high salt diet, cp/cp showed a significant increase in 24 h urinary endothelin excretion and increased renal expression of preproendothelin mRNA. There was no effect of high salt diet on renal excretion of nitric oxide (NOx) or on gene expression of endothelial, neuronal, or cytokine-induced nitric oxide synthase isoforms (eNOS, nNOS, iNOS, respectively). Treatment with bosentan prevented the high salt-induced increment in systolic blood pressure in cp/cp. This was associated with a doubling of renal NOx excretion, but without changes in eNOS, nNOS, or iNOS expression. Endothelin receptor antagonism did not normalize systolic pressure in any of the genotypes. Our studies indicate that obesity secondary to leptin resistance (cp/cp) results in increased salt sensitivity that is mediated by endothelin in the SHHF rat.
Radin
M Judith
MJ
Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210, USA. radin.1@osu.edu
Holycross
Bethany J
BJ
Hoepf
Toni M
TM
McCune
Sylvia A
SA
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D001835:Body Weight / Q000187:drug effects; D004195:Disease Models, Animal; D016232:Endothelins / Q000378:metabolism / Q000494:pharmacology*; D006973:Hypertension / Q000503:physiopathology; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D020738:Leptin / Q000378:metabolism*; D008297:Male; D009765:Obesity / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D011918:Rats, Inbred SHR; D017466:Receptors, Endothelin / Q000378:metabolism; D017673:Sodium Chloride, Dietary / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*
D016232:Endothelins; D020738:Leptin; D012333:RNA, Messenger; D017466:Receptors, Endothelin; D017673:Sodium Chloride, Dietary